I-11 Paul Baverel A novel covariate search method intended for PKPD models with nonparametric parameter distributions Wednesday 10:15-11:45 |
I-13 Benoît Beck From the Experimental Model Settings to the Physical System for Interpretable Decision Making Wednesday 10:15-11:45 |
I-17 Julie Bertrand Multiple SNP analysis with HyperLasso in Pharmacogenetic Studies using Nonlinear Mixed Effects Models Wednesday 10:15-11:45 |
I-18 Bruno Bieth Using a Systems Biology Approach to Explore Clinical Diversity and Investigate Mechanism of Drug Action: Example of the RAAS System in Hypertension Wednesday 10:15-11:45 |
I-19 Roberto Bizzotto Drug Effects on Sleep Data from a 28-Day Clinical Study in Insomniac Patients: Covariate Analysis Using a Multinomial Mixed-Effect Markov-Chain Model Wednesday 10:15-11:45 |
I-20 Marcus Björnsson Performance of non-linear mixed effects models with and without taking informative dropout into account Wednesday 10:15-11:45 |
I-25 Massoud Boroujerdi A Negative feedback model for a mechanism based description of longitudinal observations: application for bone turnover biomarkers. Wednesday 10:15-11:45 |
I-26 Marion Bouillon-Pichault Modeling Pain score in clinical trials using a joint survival-longitudinal mixed model with a Beta distribution in presence of missing values not occurring at random. Wednesday 10:15-11:45 |
I-31 Anne Brochot Specifying Models with Time Dependent Pharmacokinetic Parameters in NONMEM Wednesday 10:15-11:45 |
I-33 Vincent Buchheit Efficient quality review for modeling input dataset Wednesday 10:15-11:45 |
I-42 Marylore Chenel BSA-adjusted dose? An old method to fight old bias Wednesday 10:15-11:45 |
I-43 S. Y. Amy Cheung Structural identifiability of parallel pharmacokinetic experiments as constrained systems Wednesday 10:15-11:45 |
I-52 Emmanuelle Comets A comparison of bootstrap approaches for estimating standard errors of parameters in linear mixed effects models Wednesday 10:15-11:45 |
I-53 Carolyn Coulter Utilising prior literature population models to inform clinical practice - a dosing regimen for immediate N-acetyl cysteine treatment of paracetamol overdose Wednesday 10:15-11:45 |
I-55 Roosmarijn De Cock Maturation of GFR in preterm and term neonates reflected by clearance of different antibiotics Wednesday 10:15-11:45 |
I-58 Maud Delattre Pharmacokinetics and stochastic differential equations : model and methodology. Wednesday 10:15-11:45 |
I-64 Aris Dokoumetzidis Numerical solution of nonlinear fractional compartmental systems Wednesday 10:15-11:45 |
I-65 Aris Dokoumetzidis Multiple dosing for linear fractional pharmacokinetic systems Wednesday 10:15-11:45 |
II-13 Axel Facius Modelling and Simulation based Techniques to support Trial Design and Submission of Daxas Wednesday 14:55-16:10 |
II-19 Christina Friedrich Comparison of Statistical and Physiological Modeling Methods Using Examples in Drug Discovery and Development Wednesday 14:55-16:10 |
II-47 Vijay Ivaturi Selection Bias in Pre-Specified Covariate Models Wednesday 14:55-16:10 |
II-53 Åsa Kragh Comparison of methods for handling missing covariate data Wednesday 14:55-16:10 |
II-57 Takayuki Katsube Evaluation of Stepwise Covariate Model Building Combined with Cross-Validation Wednesday 14:55-16:10 |
II-58 Ron Keizer The bootstrap of Stepwise Covariate Modeling using linear approximations Wednesday 14:55-16:10 |
II-62 Akash Khandelwal Influence of Correlated Covariates on Predictive Performance for Different Models Wednesday 14:55-16:10 |
III-11 Natacha Lenuzza Development of a PK library of parent drug/metabolite integrated models Thursday 09:50-11:05 |
III-18 Eleonora Marostica Population state-space modelling of patient responses in antidepressant studies Thursday 09:50-11:05 |
III-19 Hafedh Marouani Kinetic nomograms assist individualization of drug regimens Thursday 09:50-11:05 |
III-23 Christophe Meille PK/PD Model of skin toxicity in animal reported as binary outcome Thursday 09:50-11:05 |
III-60 Klaas Prins Modeling urge urinary incontinence data acknowledging non-Poisson dispersion of counts within individual provides a major model fit improvement. Thursday 09:50-11:05 |
III-61 Klaas Prins Use of a generalized poisson model to describe micturition frequency in patients with overactive bladder disease. Thursday 09:50-11:05 |
IV-01 Alberto Russu Integration of response, tolerability and dropout in flexible-dose trials: a case study in depression Thursday 15:05-16:20 |
IV-14 Doerthe Steller Extension of Continuous-Time PK/PD Markov Models to Published Count Data Thursday 15:05-16:20 |
IV-23 Nadia Terranova A non parametric population approach for selecting biomarkers of a drug action Thursday 15:05-16:20 |
IV-25 Michel Tod A meta-analysis regression model for quantitative prediction of the impact of polymorphism on drug exposure Thursday 15:05-16:20 |
IV-29 Kuenhi Tsai Evaluating Bootstrap Methods in Nonlinear Mixed Effect Models (NMEM) Using a PK Model Thursday 15:05-16:20 |
IV-48 Thomas Wendl Modeling of renal failure, dialysis, inhalation and mechanical ventilation: Development of a whole-body physiologically-based pharmacokinetic (PBPK) model for ICU patients with and without renal failure receiving inhalatively administered Amikacin via a tracheal tube. Thursday 15:05-16:20 |